| Autor: |
Savinova I; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada., Tarafdar N; Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Sachdeva M; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, ON, Canada., Abduelmula A; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, ON, Canada., Maliyar K; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, ON, Canada., Georgakopoulos JR; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, ON, Canada., Mufti A; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, ON, Canada.; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Yeung J; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, ON, Canada.; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Division of Dermatology, Women's College Hospital, Toronto, ON, Canada. |
| Abstrakt: |
Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr. Yeung has been a speaker, consultant, and investigator for AbbVie, Allergan, Amgen, Astellas, Boehringer Ingelheim, Celgene, Centocor, Coherus, Dermira, Eli Lilly, Forward, Galderma, GSK, Janssen, Leo, MedImmune, Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi Genzyme, Takeda, UCB, Valeant, and Xenon. Dr. Mufti has been a speaker for AbbVie and Janssen. Dr. Sachdeva, Dr. Abduelmula, Dr. Maliyar, Dr. Georgakopoulos, Iryna Savinova, and Nawar Tarafdar have no conflicts of interest to declare. |
